Researchers have unveiled a compound named SenoVax, which, during laboratory trials, exhibited the capability to notably extend the lifespan of test subjects.
The drug’s active principle involves stimulating the immune system to eliminate senescent (aging) cells.
Consequently, animal testing revealed a full doubling of lifespan alongside enhancements in overall well-being.
Experts caution that moving toward human clinical trials necessitates several more years of thorough investigation.
About the Author
